Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop

Experimental Cell Research

Volumn 313, Issue 2, 2007, Pages 322-330

  Lai, Serene R ^a   Cunningham, Amanda P ^a   Huynh, Vu Q ^b   Andrews, Lucy G ^a   Tollefsbol, Trygve O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE

Author keywords

Cell cycle; hTERT; p21; p53; Telomerase; Telomere

Indexed keywords

MESSENGER RNA; PROTEIN P16INK4A; PROTEIN P21; PROTEIN P53; REGULATOR PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME REGULATION; FEEDBACK SYSTEM; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA INTERFERENCE; TELOMERE; UPREGULATION;

EID: 33846014619     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.10.014     Document Type: Article

References (45)

1. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Ide T., and Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18 (1998) 65-68
2. Armelin H.A., Armelin M.C.S., Kelly K., Stewart T., Leder P., Cochran B.H., and Stiles C.D. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature (London) 310 (1984) 655-660
3. Vaziri H., and Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8 (1998) 279-282
4. Wright W.E., and Shay J.W. Two-step mechanism controlling cellular senescence and immortalization. Exp. Geront. 27 (1992) 383-389
5. Greider C.W., and Telomeres. Curr. Opin. Cell Biol. 3 (1991) 444-451
6. Greider C.W., and Blackburn E.H. Telomeres, telomerase and cancer. Sci. Am. 274 (1996) 92-97
7. Greider C.W., and Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43 (1985) 405-413
8. Greider C.W., and Blackburn E.H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51 (1987) 887-898
9. Greider C.W., and Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337 (1989) 331-337
10. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Baijersbergen R.L., Davidoff M.J., Liu Q., Bacchetti S., Haber D.A., and Weinberg R.A. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells during immortalization. Cell 90 (1997) 785-795
11. Nakamura T.N., Morin G., Chapman K.B., Wienrich R.L., Andrews W.H., Lingner J., Harley C.B., and Cech T.R. Telomerase catalytic subunit homologs from fission yeast and humans. Science 277 (1997) 955-959
12. Matsutomi K., Yu E.Y., Khurts S., Ben-Porath I., Currier J.L., Metz G.B., Brooks M.W., Kaneko S., Murakami S., DeCaprio J.A., Weinberg R.A., Stewart S.A., and Hahn W.C. Telomerase maintains telomere structure in normal human cells. Cell 114 (2003) 241-253
13. Yi X., Tesmer V.M., Savre-Train I., Shay J.W., and Wright W.E. Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol. Cell. Biol. 19 (1999) 3989-3997
14. Li M., Wu Y., Liang Y.R., and Wu X.Y. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J. Gastroenterol. 9 (2003) 2395-2399
15. Cong Y.-S., Wen J., and Bacchetti S. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66 (1999) 407-425
16. Ducrest A.L., Szutorisz H., Lingner J., and Nabholz M. Regulation of the human telomerase gene. Oncogene 21 (2002) 541-552
17. Perrault S.D., Hornsby P.J., and Betts D.H. Global gene expression response to telomerase in bovine adrenocortical cells. Biochem. Biophys. Res. Commun. 335 (2005) 925-936
18. Kanaya T., Kyo S., Hamada K., Takakura M., Kitagawa Y., Harada H., and Inoue M. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin. Cancer Res. 6 (2000) 1239-1247
19. Dotto G.P. More than a break to the cell cycle?. Biochim. Biophys. Acta 1471 (2000) M43-M56
20. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., and Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366 (1993) 634-635
21. Harada K., Kurisu K., Sadamoto T., Tahara H., Tahara E., Ide T., and Tahara E. Growth inhibition of human glioma cells by transfection-induced p21 and its effects on telomerase activity. J. Neuro-Oncol. 47 (2000) 39-46
22. Hendersen Y.C., Breau R.L., Liu T.J., and Clayman G.L. Telomerase activity in head and neck tumors after introduction of wild-type p53, p21, p16, E2F-1 genes by means of recombinant adenovirus. Head Neck 22 (2000) 347-354
23. Koutsodontis G., Tentes I., Papakosta P., Moustakas A., and Kardassis D. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21WAF1/Cip1 gene by the p53 tumor suppressor protein. J. Biol. Chem. 276 (2001) 29116-29125
24. Prowse D.M., Bolgan L., Molnár A., and Dotto G.P. Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation. J. Biol. Chem. 272 (1997) 1308-1314
25. Young J.I., and Smith J.R. DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J. Biol. Chem. 276 (2001) 19610-19616
26. Louis N., Evelegh C., and Graham F.L. Cloning and sequencing of cellular viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 233 (1997) 423-429
27. Ali S., and Kukolj G. Interferon regulatory factor 3-independent double-stranded RNA-induced inhibition of hepatitis C virus replicons in human embryonic kidney 293 cells. J. Virol. 79 (2005) 3174-3198
28. Yang S., Tutton S., Pierce E., and Yoon K. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol. Cell. Biol. 21 (2001) 7807-7816
29. Billy E., Brondani V., Zhang H., Müller U., and Filipowicz W. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc. Natl. Acad. Sci. 98 (2001) 14428-14433
30. Yew P.R., and Berk A.J. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357 (1992) 82-85
31. Chen J., Lin J., and Levine A.J. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1 (1995) 142-152
32. Chen J., Wu X., and Levine A.J. Mdm-2 inhibits G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16 (1996) 2445-2452
33. Löber C., Lenz-Stöppler C., and Dobbelstein M. Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53. J. Gen. Virol. 83 (2002) 2047-2057
34. Wick M., Zubov D., and Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Genes Dev. 232 (1999) 97-106
35. Ramirez P.T., Gershenson D.M., Guillermo T.-L., Ramondetta L.M., Fightmaster D., Wharton J.T., and Wolf J.K. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16INK4a, p21WAF1/Cip-1, and p53. Gynaecol. Oncol. 83 (2001) 543-548
36. Gan Y., Mo Y., Johnston J., Lu J., Wientjes M.G., and Au J.L.-S. Telomere maintenance in telomerase-positive human ovarian SKOV-3 cells cannot be retarded by complete inhibition of telomerase. FEBS Lett. 527 (2002) 10-14
37. Shats I., Milyavsky M., Tang X., Stambolsky P., Erez N., Brosh R., Kogan I., Braunstein I., Tzukerman M., Ginsberg D., and Rotter V. p53-dependent down-regulation of telomerase is mediated by p21waf1. J. Biol. Chem. 279 (2004) 50976-50985
38. Xiang H., Wang J., Mao Y., Liu M., Reddy V.N., and Li D.W. Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating RB/E2F pathway. Oncogene 21 (2002) 3784-3791
39. Dean M., Levine R.A., and Campisi J. c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest. Mol. Cell. Biol. 6 (1986) 518-524
40. Won J., Yim J., and Kim T.K. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells. FASEB J. 16 (2002) 1943-1945
41. Liu L., Lai S., Andrews L.G., and Tollefsbol T.O. Genetic and epigenetic modulation of telomerase activity in development and disease. Gene 340 (2004) 1-10
42. Poole J.C., Andrews L.G., and Tollefsbol T.O. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 269 (2001) 1-12
43. Li Y., Li M., Peng Y., Jiang Z., Li W., and Li H. Suppression of telomerase activity by plasmid-mediated RNA interference. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 23 (2006) 615-619
44. Zheng J.N., Sun Y.F., Pei D.S., Liu J.J., C. C.J., Li W., Sun X.Q., Shi Q.D., Han R.F., and Ma T.X. Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs. Acta Biochim. Biophys. Sin. (Shanghai) 38 (2006) 500-506
45. de Souza Nascimento P., Alves G., and Fiedler W. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. Oncol. Rep. 16 (2006) 423-428